STOCK TITAN

Freightos Ltd (CRGO) VP sells 4,666 shares to cover RSU taxes

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Freightos Ltd VP Human Resources Andrea Indave Sesma reported net sales of 4,666 ordinary shares on July 16, 2026, in transactions coded as open‑market or private sales at per‑share prices between $1.27 and $1.29. The filing states each sale was made on her behalf to cover tax liability arising from vesting restricted share units (RSUs).

After these tax‑related sales, she continues to hold separate RSU‑related positions, including 24,205 ordinary shares from a 2025 grant of 28,000 RSUs, 14,643 RSUs and/or underlying ordinary shares from a 2024 grant of 19,830 RSUs, and 3,602 ordinary shares from a 2023 grant of 5,850 RSUs. A separate line shows 3,500 ordinary shares held for informational purposes, and she also holds stock options over 5,629 and 7,476 underlying ordinary shares at exercise prices of $4.17 and $1.45, expiring in 2032 and 2029, respectively.

Positive

  • None.

Negative

  • None.
Insider Indave Sesma Andrea
Role VP, Human Resources
Sold 4,666 shs ($6K)
Type Security Shares Price Value
Sale Ordinary Shares F1, F2 199 $1.27 $252.73
Sale Ordinary Shares F1, F3, F4 672 $1.28 $860.16
Sale Ordinary Shares F1, F5 3,795 $1.29 $5K
holding Stock Option (right to buy) F6 -- -- --
holding Stock Option (right to buy) F6 -- -- --
holding Ordinary Shares F6 -- -- --
Holdings After Transaction: Ordinary Shares — 27,705 shares (Direct); Stock Option (right to buy) — 13,105 shares (Direct)
Footnotes (6)
  1. F1. The transaction reported in this row consists of a sale on behalf of the Reporting Person to cover tax liability for vesting of restricted share units ("RSUs") that had been granted by the Issuer to the Reporting Person.
  2. F2. The ordinary shares reported in this row consist of the remaining shares (following sales to cover tax liability) underlying 5,850 RSUs originally granted by the Issuer to the Reporting Person that began vesting (and settling for underlying ordinary shares) on July 15, 2023. Such RSUs (reduced by any RSUs for which underlying shares have been sold to cover tax liability) are now fully vested and have been settled for underlying ordinary shares. In addition to the 199 shares sold as reported in this row and the 193 shares from this grant sold on April 16, 2026 as reported in the Form 4 filed on April 20, 2026, an additional 1,856 shares were sold to cover tax liability previously (before the Reporting Person was subject to Section 16), such that only 3,602 ordinary shares are currently held by the Reporting Person from the 5,850 RSUs originally granted.
  3. F3. The ordinary shares reported in this row consist of the remaining shares (following sales to cover tax liability) underlying 19,830 RSUs originally granted by the Issuer to the Reporting Person that began vesting (and settling for underlying ordinary shares) on July 15, 2024. Such RSUs vest in accordance with the following schedule: 33.33% of those RSUs vested upon the one-year anniversary of the vesting commencement date and the remaining RSUs vest equally on a quarterly basis over the following eight quarters (8.3325% per quarter) such that all such RSUs (reduced by any RSUs for which underlying shares are sold to cover tax liability) will be fully vested by July 15, 2027.
  4. F4. In addition to the 672 shares sold as reported in this row and the 653 shares from this grant sold on April 16, 2026 as reported in the Form 4 filed on April 20, 2026, an additional 3,862 shares were sold to cover tax liability previously (before the Reporting Person was subject to Section 16), such that only 14,643 RSUs and/or underlying ordinary shares are currently held by the Reporting Person from the 19,830 RSUs originally granted.
  5. F5. The ordinary shares reported in this row consist of the remaining shares (following sales to cover tax liability) underlying 28,000 RSUs originally granted by the Issuer to the Reporting Person that began vesting (and settling for underlying ordinary shares) on July 15, 2025. Such RSUs vest in accordance with the following schedule: 33.33% of those RSUs vested upon the one-year anniversary of the vesting commencement date (July 15, 2026), and the remaining RSUs vest equally on a quarterly basis over the following eight quarters (8.3325% per quarter) such that all such RSUs (reduced by any RSUs for which underlying shares are sold to cover tax liability) will be fully vested by July 15, 2028.
  6. F6. There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.
Total shares sold 4,666 ordinary shares Aggregate ordinary shares sold on 2026-07-16 across three Form 4 transactions
Sale 1 3,795 ordinary shares at $1.29 Ordinary share sale on 2026-07-16 tied to a 28,000 RSU grant; tax-liability sale
Sale 2 672 ordinary shares at $1.28 Ordinary share sale on 2026-07-16 from a 19,830 RSU grant; tax-liability sale
Sale 3 199 ordinary shares at $1.27 Ordinary share sale on 2026-07-16 from a 5,850 RSU grant; tax-liability sale
Remaining shares from 2025 RSUs 24,205 ordinary shares Remaining shares underlying 28,000 RSUs granted, after sales to cover tax liability
Remaining 2024 RSU position 14,643 RSUs and/or underlying ordinary shares Held from 19,830 RSUs granted after prior tax-covering sales
Stock option at $4.17 5,629 underlying shares at $4.17 Stock option over ordinary shares expiring on 2032-02-17, held directly
Stock option at $1.45 7,476 underlying shares at $1.45 Stock option over ordinary shares expiring on 2029-11-06, held directly
restricted share units ("RSUs") financial
"sale on behalf of the Reporting Person to cover tax liability for vesting of restricted share units ("RSUs")"
vesting commencement date financial
"Such RSUs vest in accordance with the following schedule... anniversary of the vesting commencement date"
The vesting commencement date is the starting point when an employee begins earning ownership rights to their promised benefits, such as stock options or retirement contributions. Think of it like the day a savings account is opened—only after this date do the benefits start to grow and become fully available over time. It matters to investors because it marks when the clock begins ticking toward full ownership, affecting the timing and value of these benefits.
Section 16 regulatory
"sold to cover tax liability previously (before the Reporting Person was subject to Section 16)"
Section 16 is a U.S. securities law rule that governs the trading and disclosure obligations of company insiders — typically officers, directors and large shareholders — to promote transparency and deter unfair profit-taking. It requires insiders to publicly report their stock trades and allows companies or the issuer to reclaim quick, short-term profits from certain insider trades, like a scoreboard and a refund policy that help investors see and limit possible insider advantage.
underlying ordinary shares financial
"RSUs originally granted by the Issuer... and settling for underlying ordinary shares"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What did Freightos Ltd (CRGO) report about Andrea Indave Sesma’s insider transactions on July 16, 2026?

Freightos Ltd reported that VP Human Resources Andrea Indave Sesma sold 4,666 ordinary shares on July 16, 2026. The transactions were coded as sales in open‑market or private transactions, with all sales made to cover tax liabilities from vesting RSUs granted by the company.

How many Freightos Ltd (CRGO) shares did Andrea Indave Sesma sell and at what prices?

Andrea Indave Sesma sold a total of 4,666 ordinary shares of Freightos Ltd. The sales comprised 3,795 shares at $1.29, 672 shares at $1.28, and 199 shares at $1.27 per share, all on July 16, 2026, to cover RSU‑related tax liabilities.

Why were the Freightos Ltd (CRGO) shares sold by Andrea Indave Sesma according to the Form 4 footnotes?

The Form 4 states that each reported sale was executed on behalf of Andrea Indave Sesma to cover tax liability for vesting restricted share units (RSUs). These RSUs had been previously granted by Freightos Ltd and were settling into underlying ordinary shares as they vested.

What other Freightos Ltd (CRGO) equity holdings and options does Andrea Indave Sesma report?

In addition to RSU‑related positions, a separate informational line shows 3,500 ordinary shares held directly. She also reports stock options over 5,629 underlying shares at $4.17 expiring February 17, 2032, and 7,476 underlying shares at $1.45 expiring November 6, 2029.

Does the Freightos Ltd (CRGO) Form 4 indicate any option exercises by Andrea Indave Sesma?

The Form 4 lists stock options with exercise prices of $4.17 and $1.45 over 5,629 and 7,476 underlying shares, respectively, but marks these as holdings only. A footnote clarifies there were no transactions in these securities; they are reported for informational purposes.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Indave Sesma Andrea

(Last)(First)(Middle)
C/O FREIGHTOS LIMITED, PLANTA 10
AVDA. DIAGONAL, 211

(Street)
BARCELONA08018

(City)(State)(Zip)

SPAIN

(Country)
2. Issuer Name and Ticker or Trading Symbol
Freightos Ltd [ CRGO ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
VP, Human Resources
2a. Foreign Trading Symbol
[N/A]
3. Date of Earliest Transaction (Month/Day/Year)
07/16/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Ordinary Shares07/16/2026S(1)199D$1.273,602(2)D
Ordinary Shares07/16/2026S(1)672D$1.2814,643(3)(4)D
Ordinary Shares07/16/2026S(1)3,795D$1.2924,205(5)D
Ordinary Shares(6)3,500D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (right to buy)(6)$1.4508/03/202311/06/2029Ordinary Shares7,4767,476D
Stock Option (right to buy)(6)$4.1701/01/202602/17/2032Ordinary Shares5,6295,629D
Explanation of Responses:
1. The transaction reported in this row consists of a sale on behalf of the Reporting Person to cover tax liability for vesting of restricted share units ("RSUs") that had been granted by the Issuer to the Reporting Person.
2. The ordinary shares reported in this row consist of the remaining shares (following sales to cover tax liability) underlying 5,850 RSUs originally granted by the Issuer to the Reporting Person that began vesting (and settling for underlying ordinary shares) on July 15, 2023. Such RSUs (reduced by any RSUs for which underlying shares have been sold to cover tax liability) are now fully vested and have been settled for underlying ordinary shares. In addition to the 199 shares sold as reported in this row and the 193 shares from this grant sold on April 16, 2026 as reported in the Form 4 filed on April 20, 2026, an additional 1,856 shares were sold to cover tax liability previously (before the Reporting Person was subject to Section 16), such that only 3,602 ordinary shares are currently held by the Reporting Person from the 5,850 RSUs originally granted.
3. The ordinary shares reported in this row consist of the remaining shares (following sales to cover tax liability) underlying 19,830 RSUs originally granted by the Issuer to the Reporting Person that began vesting (and settling for underlying ordinary shares) on July 15, 2024. Such RSUs vest in accordance with the following schedule: 33.33% of those RSUs vested upon the one-year anniversary of the vesting commencement date and the remaining RSUs vest equally on a quarterly basis over the following eight quarters (8.3325% per quarter) such that all such RSUs (reduced by any RSUs for which underlying shares are sold to cover tax liability) will be fully vested by July 15, 2027.
4. In addition to the 672 shares sold as reported in this row and the 653 shares from this grant sold on April 16, 2026 as reported in the Form 4 filed on April 20, 2026, an additional 3,862 shares were sold to cover tax liability previously (before the Reporting Person was subject to Section 16), such that only 14,643 RSUs and/or underlying ordinary shares are currently held by the Reporting Person from the 19,830 RSUs originally granted.
5. The ordinary shares reported in this row consist of the remaining shares (following sales to cover tax liability) underlying 28,000 RSUs originally granted by the Issuer to the Reporting Person that began vesting (and settling for underlying ordinary shares) on July 15, 2025. Such RSUs vest in accordance with the following schedule: 33.33% of those RSUs vested upon the one-year anniversary of the vesting commencement date (July 15, 2026), and the remaining RSUs vest equally on a quarterly basis over the following eight quarters (8.3325% per quarter) such that all such RSUs (reduced by any RSUs for which underlying shares are sold to cover tax liability) will be fully vested by July 15, 2028.
6. There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.
Remarks:
Exhibit List: Exhibit 24.1 - Power of Attorney.
/s/ Max Sitnick, Attorney-in-fact07/20/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)